Integrated Services

Integrated Services
Product Description

Huayi Pharmaceuticals offers an integrated service for product development with our partners Weida Clinical Research and Velocyte Analytical Technology for your bioequivalence needs in China. Through these close strategic partnerships, we are able to offer a one-stop service which allows pharmaceutical development, dissolution profiling, stability studies, bio-equivalence studies, testing of plasma samples and commercial manufacture. Having these integrated services ensures the success of your projects, shortens the time taken for R&D and keeps your project cost-effective. The integrated service is particularly attractive for clients that want to develop products for the Chinese domestic market or for both the Chinese and European markets. 

Read more Show less

Huayi Pharmaceuticals(Anhui)Co.,Ltd

  • CN
  • 2021
    On CPhI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Contract Service
View company profile
Categories
more categories Show less

Huayi Pharmaceuticals(Anhui)Co.,Ltd

  • CN
  • 2021
    On CPhI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Contract Service
View company profile

More Products from Huayi Pharmaceuticals(Anhui)Co.,Ltd

  • Pharmaceutical Development

    Product Pharmaceutical Development

    PreformulationSolubility/stability assessmentExcipient screeningAPI properties for processability

    Formulation developmentSolid dosePowdersTablets: sublingual, dispersible, effervescent, gastro-risistant, sugar and film-coatedCapsules, hard gel: pellets, double-component, granules, powders, enteric-coatedOral liquidsModified release to match a specific dissolution profileReverse formulation engineeringClinical trial supply manufacturingClinical to commercial scale-up

    AnalysisAnalytical method development
    Technology transfer
    Validation of methods for clinical and commercial applications
    Bespoke stability testing for accelerating product degradation and ICH stability testing for shelf life determination of finished drug products
  • Contract Manufacturing

    Product Contract Manufacturing

    Solid dosage forms including tablets in various forms (film-coated, sugar-coated, enteric-coated, effervescent, soluble, chewable, buccal) and capsules filled with powders or pellets. 
    Over 50 products are commercially manufactured for several European countries including some products developed from scratch by our R&D team.

    Production capacity is 3 billion units currently and we manufactured 2 billion tablets/capsules. 
    Facilities for oral liquids and high potency products have been invested and are ready in 2020.

    Capacity to be expanded to 10 billlion tablets/capsules in 2024 when new facility is put inot use.

  • Commercial Packaging

    Product Commercial Packaging

    Huayi’s packing lines are FMD compliant and enable clinical, commercial and stability blister and pot packing. We can help customise blister packaging to your exact specifications with image and character registration as well as perforations.
    Clinical, commercial and stability packaging

    - PVC, PVC/PVDC, PCV/PE/PVDC, Aclar
    - Alu/Alu (including cold form)
    - Bottle filling and labelling
    - Tamper-evident sealing
    - 2D matrix serialisation

Huayi Pharmaceuticals(Anhui)Co.,Ltd resources

  • Huayi passed remote GMP re-inspection by MHRA

    News Huayi passed remote GMP re-inspection by MHRA

    On 23rd June, 2021, Huayi passed remote GMP re-inspection by MHRA including new workshops for moderately potency product and oral liquid.
    24 Nov 2021
  • Huayi Pharmaceuticals

    Video Huayi Pharmaceuticals

    Huayi Pharmaceutical (Anhui) Co. Ltd. is an EU cGMP approved Sino-British joint venture located in Hefei, Eastern China. We manufacture quality generic medicines on a contractual basis for EU and Chinese customers with competitive pricing.